This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction Note: MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
Nana Li, Yuan Miao, Yujia Shan, Bing Liu, Yang Li, Lifen Zhao, Li Jia
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPI3K/AKT/mTOR signaling in cancer · MicroRNA in disease regulation · Circular RNAs in diseases
Retraction Note to: Cell Death & Disease 10.1038/cddis.2017.119, published online 18 May 2017
The Editors-in-Chief have retracted this article. Concerns were raised regarding a number of figures, specifically:
- Figure 2j: the panels for anti-miR-106b and anti-miR-93 appear to partially overlap.
- Figure 6a: panel 3 (left) and panel 3 (right) for MDA-MB-231 appear to partially overlap.
The Editors-in-Chief therefore no longer have confidence in the reliability of the data reported in the article.
Author Li Jia has stated on behalf of all authors that they disagree with this retraction.